Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Intravitreal dexamethasone implant 0.7 mg vs antiVEGF

Surgery for glaucoma ‐ 24 months · macular edema in diabetes

It is very uncertain whether intravitreal dexamethasone implant 0.7 mg changes surgery for glaucoma ‐ 24 months compared with intravitreal antiVEGF (very low certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 3.02 [0.12, 73.56]
Studies not reported
Very low

Intravitreal dexamethasone implant 0.7 mg vs sham

Surgery for glaucoma · macular edema in diabetes

Intravitreal dexamethasone implant 0.7 mg showed no clear difference in surgery for glaucoma ‐ 36 months compared with sham (low certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 5.04 [0.59, 42.95]
1 study · 697 participants
Low